Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuhiro Wada

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Anatomical Science International|June 22, 2016
Pleiotropic and retinoprotective functions of PACAPSeiji Shioda, Fumiko Takenoya, Nobuhiro Wada, et al.
The Journal of Nutritional Biochemistry|November 2, 2023
Fish oil-derived n-3 polyunsaturated fatty acids downregulate aquaporin 9 protein expression of liver and white adipose tissues in diabetic KK mice and 3T3-L1 adipocytesYuzuru Iizuka, Satoshi Hirako, Hyounju Kim, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 20, 2016
Autonomic nervous system-mediated effects of GALP on energy metabolismSatoshi Hirako, Nobuhiro Wada, Haruaki Kageyama, et al.
Journal of Chemical Neuroanatomy|September 15, 2014
Leptin and its receptorsNobuhiro Wada, Satoshi Hirako, Fumiko Takenoya, et al.
Heliyon|April 24, 2020
Excessive folic acid supplementation in pregnant mice impairs insulin secretion and induces the expression of genes associated with fatty liver in their offspringYuri Kintaka, Nobuhiro Wada, Seiji Shioda, et al.
Current Pharmaceutical Design|November 7, 2018
Regulation of Feeding Behavior and Energy Metabolism by Galanin-like Peptide (GALP): A Novel Strategy to Fight Against ObesityFumiko Takenoya, Satoshi Hirako, Nobuhiro Wada, et al.
Journal of Molecular Neuroscience : MN|June 23, 2018
Effects of PACAP on Dry Eye Symptoms, and Possible Use for Therapeutic ApplicationSeiji Shioda, Fumiko Takenoya, Takahiro Hirabayashi, et al.
Frontiers in Endocrinology|December 26, 2012
Neuropeptide wFumiko Takenoya, Haruaki Kageyama, Satoshi Hirako, et al.
Pharmacology Research & Perspectives|June 16, 2022
The sodium-glucose co-transporter 2 inhibitor tofogliflozin suppresses atherosclerosis through glucose lowering in ApoE-deficient mice with streptozotocin-induced diabetesMasahiko Iwamoto, Tetsuya Kubota, Yoshitaka Sakurai, et al.
Current Pharmaceutical Design|March 23, 2017
Effect of Intranasal Administration of Galanin-like Peptide (GALP) on Body Weight and Hepatic Lipids Accumulation in Mice with Diet-induced ObesitySatoshi Hirako, Nobuhiro Wada, Haruaki Kageyama, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Anatomical Science International|June 22, 2016
Pleiotropic and retinoprotective functions of PACAPSeiji Shioda, Fumiko Takenoya, Nobuhiro Wada, et al.
The Journal of Nutritional Biochemistry|November 2, 2023
Fish oil-derived n-3 polyunsaturated fatty acids downregulate aquaporin 9 protein expression of liver and white adipose tissues in diabetic KK mice and 3T3-L1 adipocytesYuzuru Iizuka, Satoshi Hirako, Hyounju Kim, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 20, 2016
Autonomic nervous system-mediated effects of GALP on energy metabolismSatoshi Hirako, Nobuhiro Wada, Haruaki Kageyama, et al.
Journal of Chemical Neuroanatomy|September 15, 2014
Leptin and its receptorsNobuhiro Wada, Satoshi Hirako, Fumiko Takenoya, et al.
Heliyon|April 24, 2020
Excessive folic acid supplementation in pregnant mice impairs insulin secretion and induces the expression of genes associated with fatty liver in their offspringYuri Kintaka, Nobuhiro Wada, Seiji Shioda, et al.
Current Pharmaceutical Design|November 7, 2018
Regulation of Feeding Behavior and Energy Metabolism by Galanin-like Peptide (GALP): A Novel Strategy to Fight Against ObesityFumiko Takenoya, Satoshi Hirako, Nobuhiro Wada, et al.
Journal of Molecular Neuroscience : MN|June 23, 2018
Effects of PACAP on Dry Eye Symptoms, and Possible Use for Therapeutic ApplicationSeiji Shioda, Fumiko Takenoya, Takahiro Hirabayashi, et al.
Frontiers in Endocrinology|December 26, 2012
Neuropeptide wFumiko Takenoya, Haruaki Kageyama, Satoshi Hirako, et al.
Pharmacology Research & Perspectives|June 16, 2022
The sodium-glucose co-transporter 2 inhibitor tofogliflozin suppresses atherosclerosis through glucose lowering in ApoE-deficient mice with streptozotocin-induced diabetesMasahiko Iwamoto, Tetsuya Kubota, Yoshitaka Sakurai, et al.
Current Pharmaceutical Design|March 23, 2017
Effect of Intranasal Administration of Galanin-like Peptide (GALP) on Body Weight and Hepatic Lipids Accumulation in Mice with Diet-induced ObesitySatoshi Hirako, Nobuhiro Wada, Haruaki Kageyama, et al.
Pageof 3